Plain-English translation of NCT05326061 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study — meaning researchers are not testing a new medication, but rather learning more about people at higher risk for HIV infection. The study will gather detailed information about sexual health, lifestyle factors, and prevention methods like pre-exposure prophylaxis (PrEP), along with blood, urine, and other samples. By understanding these patterns, researchers hope to improve HIV prevention strategies.
Many people remain at significant risk for HIV despite available prevention tools. This study exists to better understand who is at highest risk, why, and what barriers or challenges they face — so that future prevention programs and services can be more effective and better tailored.
You likely qualify if…
You likely don't qualify if…
You would visit the research site to meet with a healthcare provider who will ask detailed questions about your sexual health, relationships, and lifestyle. You will also provide biological samples — blood, urine, and possibly other samples — which will be tested for HIV and sexually transmitted infections. The study does not involve taking any new medication; it is focused on gathering information and samples to help researchers understand HIV risk better.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Austria
Medical University of Vienna
Enrollment target
~500 participants
Started
July 2020
Primary completion
December 2030
Age range
18 Years – 100 Years
Last updated on clinicaltrials.gov in April 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
David Chromy, MD
Medical University of Vienna
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.